Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
38 Cards in this Set
- Front
- Back
tissue factor activates what clotting factor first?
|
factor VII
|
|
what is the first protease in teh common pathway?
|
factor X
|
|
what activates the conversion of X to Xa?
|
Va (a binding protein)
|
|
is factor VIIIa a binding protein or a protease?
|
binding protein
|
|
what factor is responsible for creating cross-linked fibrin?
|
XIIIa
|
|
list the 5 endogenous ways in which termination of clotting occurs
|
1. dilution of factors in flowing blood
2. trapping of proteases in the clot 3. plasma protease inhibitors such as antithrombin 4. thrombomodulin - protein S - protein C cascade 5. plasminogen activation by tPa (tissue type factor), streptokinase, uPA (urokinase) to form plasmin which cleaves triple helix of fibrin |
|
what is cleaved from fibrinogen to form fibrin?
|
4 alpha knobs of the fibrinopeptides
|
|
vit K required for which factors?
|
2 (prothrombin), VII, IX, X
|
|
why do 2,8,9,10 need vit K?
|
to catalyze the carboxylation of their glu amino acids
|
|
once the glu aa's are carboxylated to form Gla, what is the next step
|
binding of calcium; the complex them binds to the phospholipid membrane at the site of injury
|
|
describe the thrombomodulin protein c protein s pathway
|
essentially thrombomodulin is made by teh endothelial cell membrane and convets throbin from a procoagulant to an anti-coagulant. it does this by activating protein C and protein S. These proteins are going to inactivate factors Va and VIIIa
|
|
what are 3 exogenous ways to terminate clotting/
|
1. warfarin - competitive antag with K; prevents carboxylation of glu
2. heparin - speeds up rxn of AT and thrombin 3. metal chelators such as citrate - strip calcium from Gla proteins |
|
what is factor V leiden/
|
mutation on factor V binding site for protein C
|
|
what are some ways in which a malignancy can cause hypercoag?
|
-results in the patient being static
-venous obstruction -release of procoagulants by the cancer |
|
is estrogen (via HRT, BCP) considered a RF for coagulation?
|
yes
|
|
why will recent surgery increase risk for coagulation
|
causing vascular injury (one ot the things in virchow's triangle)
|
|
why is Tamoxifen a/w coagulation
|
it is a chemotherapeutic agent containing estrogen - and estrogen is a/w coagulation
|
|
how does the V/Q ratio differ in pulm embolism vs. in other disease stages that cause regional defects in lung perfusino (e.g. emphysema, pulmonary atresia)
|
in PE, you have V/Q mismatching. Other pulmonary conditions such as COPD, asthma, pneumonia and pulmonary edema tend to cause both decreased V and Q (matched V/Q defect)
|
|
what ist eh gold stadard for visualizing thromboses in periphery? in pulmonary vasculature?
|
contrast venography
pulmonary angiography |
|
is MRI more effective at imaging peripheral or pulmonary emboli?
|
peripheral. B/c in lung, there is poor signal/noise ratio in air filled lungs
|
|
what is the correct order for the algorithm for PE?
-spiral CT -MRI -CXR -leg doppler -pulmonary angiography -V/P scintigraphy (nuclear med) |
-CXR (frequently normal; do this to rule out DDx like atelectasis)
-Spiral CT - poor sensitivity as we go through distal branches, good specificity -Leg doppler -V/P scintigraphy - if normal, can rule out PE -pulmonary angiography - GOLD STANDARD - but a/w morbidity & mort |
|
are ABGs helpful in PE?
|
-not really.
-you migth see hypoxemia -will see hypercapnia |
|
what is the normal INR? waht is the target INR if youre on warfarin?
|
normal INR: 1
on warfarin: 2-3 |
|
which one do you need to closely monitor SUH or LMWH? why?
|
SUH b/c its highly protein bound
|
|
what is heparin-induced thrombocytopenia?
|
immune mediated- causes platelet aggregation --> thrombosis
|
|
heparin and warfarin. which is immediate acting? which is delayed acting?
|
warfarin = delayed
heparin = immediate |
|
can you use thrombolytics and fibrinolytics simultaneously?
|
no!! too large a bleeding risk
|
|
indications for thrombolytic therapy?
|
1. major PE (i.e. a/w hypotension, RH failure, severe hypoxemia)
2. submassive PE - if pt has previous heart/pulm condition 3. proximal vein thrombosis (certain cases) |
|
what are teh thrombolytic agents?
|
streptokinase
urokinase tissue plasminogen activator |
|
waht are teh 4 major options for VTE therapy?
|
1. anticoags
2. fibrinolytics 3. thrombectomy 4. caval interruption |
|
is surgical thrombectomy common? when would we use it?
|
not common at all
would use it if there way acute recurrence of an embolus (e.g. if a vein was de-endothelialized it owuld be highly thrombogenic) |
|
what is caval interruption?
|
placement of filter in IVC - traps bl clots
|
|
D2E fragments are cleared by...
|
the liver
|
|
what PTT do you want to achieve when administering heparin IV?
|
1.5-2.5 x baseline PTT
|
|
why might you see (rarely) hemoptysis with Pulm embolism? (i.e. what would it indiate?)
|
lung infarct (rare b/c of dual circulation to lungs)
|
|
what are characteristic features of ABGs and A-a gradient in pulm embolism
|
PaO2 decreased (hypoxemia)
PaCO2 usually decreased (respiratory compensation by hyperventilation) A-a gradient will be elevated |
|
what sided heart failure is characteristic of pulm embolism?
|
RH failure
|
|
would you expect displacement of hte interventricular septum to the R or L side of the heart in pulm embolism?
|
into the left (since the pulmonary circuit is hi pressure now - RH will become hypertrophied)
|